Cargando…
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1–5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs that recruit phosphatases to negatively regulate immune activation. The activation of LILRB signaling in immune cells may contribute to immune evasion....
Autores principales: | Deng, Mi, Chen, Heyu, Liu, Xiaoye, Huang, Ryan, He, Yubo, Yoo, Byounggyu, Xie, Jingjing, John, Samuel, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944505/ https://www.ncbi.nlm.nih.gov/pubmed/33928233 http://dx.doi.org/10.1093/abt/tbab002 |
Ejemplares similares
-
Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
por: Kang, Xunlei, et al.
Publicado: (2015) -
Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer
por: Fan, Jing, et al.
Publicado: (2022) -
LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis
por: Wu, Guojin, et al.
Publicado: (2021) -
Blocking LAIR1 signaling in immune cells inhibits tumor development
por: Xie, Jingjing, et al.
Publicado: (2022) -
Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5
por: Truong, Anh Duc, et al.
Publicado: (2019)